News | June 21, 2010

New Study Shows Erectile Dysfunction Could Be Marker for Heart Attack

June 21, 2010 – Seven out of 10 men admitted to hospital for a heart attack, or acute ST segment elevation myocardial infarction (STEMI), had erectile dysfunction (ED) in the six months prior to their admission, according to new data presented last week at the World Congress of Cardiology Scientific Sessions in Beijing, China.

A year-long study conducted in 2009 involving 111 sexually active men admitted for STEMI at the University Malaya Medical Centre demonstrated that 75.7 percent had experienced ED in the six months prior to being hospitalized, and all patients with a prior history of ischemic heart disease had ED. Moreover, 24.7 percent of the 81 sexually inactive men that were not recruited to the study reported complete ED for more than six months prior to screening.

ED and coronary artery disease (CAD) share many common risk factors and are closely related. Atherosclerosis, the root cause of CAD and ED, is a generalized inflammatory disorder that progresses at a similar rate throughout the vasculature of the body. Therefore, it is thought that ED should precede CAD since the penile arteries are considerably smaller than the coronary arteries.

“This study demonstrates that we should consider patients with evidence of ED to be of very high risk for development of future acute coronary syndromes. Interestingly, the study also found that all patients with a prior history of heart attack and ED presented with recurrent heart attacks. Therefore, we should screen and treat such patients very aggressively,” said Dr. S. V. Ramesh, University of Malay Medical Centre, Kuala Lumpur, Malaysia. “Moreover, men who are not sexually active should also be closely assessed, as a quarter of them have complete ED which warrants treatment, and this may also be a harbinger for CAD.”

A total of 219 men were admitted for STEMI to the coronary care unit from April 2008 to February 2009. Of these, 192 were screened and only 111 who were sexually active within the last six months were recruited for the assessment of ED using the IIEF-5 questionnaire. Other indices studied include the cardiovascular (CV) risk factors, body measurements, blood results and coronary angiographic findings.

For more information: www.worldcardiocongress.org


Related Content

News | Cardiovascular Clinical Studies

June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an ...

Home June 11, 2025
Home
News | Cardiovascular Clinical Studies

May 27, 2025 — Despite scientific advances in cardiovascular care, people in living in rural areas and other communities ...

Home May 27, 2025
Home
News | Cardiovascular Clinical Studies

May 20, 2025 — Shockwave Medical, Inc., part of Johnson & Johnson MedTechhas announced the 30-day primary endpoint ...

Home May 21, 2025
Home
News | Cardiovascular Clinical Studies

Jan. 13, — A new cohort study among 103,642 adults found that current use of cigars was associated with increased risk ...

Home January 14, 2025
Home
News | Cardiovascular Clinical Studies

Nov. 22, 2024 — BridgeBio Pharma, Inc. recently announced that the U.S. Food and Drug Administration (FDA) approved ...

Home November 25, 2024
Home
News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
Subscribe Now